Financial Review: Remedent (REMI) and Its Peers

Risk & Volatility

Remedent has a beta of -0.03, indicating that its share price is 103% less volatile than the S&P 500. Comparatively, Remedent’s competitors have a beta of 0.59, indicating that their average share price is 41% less volatile than the S&P 500.

Profitability

This table compares Remedent and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Remedent	N/A	N/A	N/A
Remedent Competitors	2.88%	-3.91%	7.65%

Insider & Institutional Ownership

69.6% of shares of all “MED/DENTAL – SUPP” companies are held by institutional investors. 9.4% of shares of all “MED/DENTAL – SUPP” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares Remedent and its competitors top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Remedent	$990,000.00	-$270,000.00	-1.00
Remedent Competitors	$37.38 billion	$430.42 million	19.60

Remedent’s competitors have higher revenue and earnings than Remedent. Remedent is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Remedent competitors beat Remedent on 8 of the 9 factors compared.

About Remedent

Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient’s teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.